Articles
Imprint Codes for Oral Medications
What are Imprint Codes?
All approved prescription and over-the-counter solid, oral dosage form medications in the U.S. are required by the Food and Drug Administration...
Articles
Antibiotics and Birth Control Pill Interactions: Fact or Fallacy?
Are you concerned when you receive an antibiotic prescription but you also take oral contraceptives? For many years, women were counseled that their birth...
Articles
Anabolic Steroids – Abuse, Side Effects and Safety
What are Anabolic Steroids?Androgens and anabolic steroids include the endogenous male sex hormone testosterone and dihydrotestosterone, and other agents that behave like these sex...
Articles
10 ways to improve your symptoms if you’re an adult with ADHD
1. What works for one person may not work for all
Medicines used to treat ADHD are usually described as stimulants (ie, Ritalin, Concerta, Dexedrine,...
Articles
Acute Bronchitis in Adults
What Is Acute Bronchitis?
You know that nagging cough - the one that seems to linger for days or even weeks? It may be acute...
Clinical Trials
Results from Phase 3 Trial of Defibrotide for the Treatment of Severe Veno-Occlusive Disease and Multi-Organ Failure Published Online
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that data from the phase 3 pivotal study of defibrotide were published online in BLOOD, the Journal...
Drug Research
Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT (Amphetamine Extended-Release Orally Disintegrating Tablet) for ADHD
Neos Therapeutics, Inc, a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR) product candidates for the treatment of attention-deficit/hyperactivity disorder (ADHD) announced...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read